Is It Too Late to Buy CVS Health Stock for the High-Yield Dividend?
After underperforming throughout 2024, shares of CVS Health (NYSE: CVS) are surging. From the end of 2024 through Feb. 14, the stock climbed 46.7% higher.Shares of the healthcare conglomerate stock notched significant gains after management presented an encouraging fourth-quarter earnings report on Wednesday, Feb. 12. Adjusted earnings that reached $1.19 per share were 29% above the average estimate from Wall Street analysts who follow the company.CVS Health stock is way up but still offers a juicy 4% dividend yield at recent prices. Could it be a smart buy now for income-seeking investors? Below, I'll weigh some of the company's strengths against its weaknesses to find out.Continue reading
After underperforming throughout 2024, shares of CVS Health (NYSE: CVS) are surging. From the end of 2024 through Feb. 14, the stock climbed 46.7% higher.
Shares of the healthcare conglomerate stock notched significant gains after management presented an encouraging fourth-quarter earnings report on Wednesday, Feb. 12. Adjusted earnings that reached $1.19 per share were 29% above the average estimate from Wall Street analysts who follow the company.
CVS Health stock is way up but still offers a juicy 4% dividend yield at recent prices. Could it be a smart buy now for income-seeking investors? Below, I'll weigh some of the company's strengths against its weaknesses to find out.
